AXON
Price
$497.13
Change
-$42.56 (-7.89%)
Updated
Apr 4 closing price
Capitalization
38.65B
38 days until earnings call
CHRS
Price
$0.78
Change
-$0.04 (-4.88%)
Updated
Apr 4 closing price
Capitalization
94.72M
33 days until earnings call
Ad is loading...

AXON vs CHRS

Header iconAXON vs CHRS Comparison
Open Charts AXON vs CHRSBanner chart's image
Axon Enterprise
Price$497.13
Change-$42.56 (-7.89%)
Volume$971.55K
Capitalization38.65B
Coherus BioSciences
Price$0.78
Change-$0.04 (-4.88%)
Volume$1.88M
Capitalization94.72M
AXON vs CHRS Comparison Chart
Loading...
AXON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CHRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AXON vs. CHRS commentary
Apr 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AXON is a Hold and CHRS is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 05, 2025
Stock price -- (AXON: $539.69 vs. CHRS: $0.82)
Brand notoriety: AXON and CHRS are both not notable
AXON represents the Aerospace & Defense, while CHRS is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: AXON: 74% vs. CHRS: 125%
Market capitalization -- AXON: $38.65B vs. CHRS: $94.72M
AXON [@Aerospace & Defense] is valued at $38.65B. CHRS’s [@Biotechnology] market capitalization is $94.72M. The market cap for tickers in the [@Aerospace & Defense] industry ranges from $177.92B to $0. The market cap for tickers in the [@Biotechnology] industry ranges from $296.36B to $0. The average market capitalization across the [@Aerospace & Defense] industry is $16.58B. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AXON’s FA Score shows that 1 FA rating(s) are green whileCHRS’s FA Score has 0 green FA rating(s).

  • AXON’s FA Score: 1 green, 4 red.
  • CHRS’s FA Score: 0 green, 5 red.
According to our system of comparison, AXON is a better buy in the long-term than CHRS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AXON’s TA Score shows that 3 TA indicator(s) are bullish while CHRS’s TA Score has 4 bullish TA indicator(s).

  • AXON’s TA Score: 3 bullish, 2 bearish.
  • CHRS’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, AXON is a better buy in the short-term than CHRS.

Price Growth

AXON (@Aerospace & Defense) experienced а -1.99% price change this week, while CHRS (@Biotechnology) price change was -4.03% for the same time period.

The average weekly price growth across all stocks in the @Aerospace & Defense industry was -3.95%. For the same industry, the average monthly price growth was -6.88%, and the average quarterly price growth was +11.85%.

The average weekly price growth across all stocks in the @Biotechnology industry was -10.73%. For the same industry, the average monthly price growth was -16.65%, and the average quarterly price growth was -18.36%.

Reported Earning Dates

AXON is expected to report earnings on May 13, 2025.

CHRS is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Aerospace & Defense (-3.95% weekly)

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

@Biotechnology (-10.73% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AXON($38.7B) has a higher market cap than CHRS($94.7M). AXON has higher P/E ratio than CHRS: AXON (112.44) vs CHRS (3.27). AXON YTD gains are higher at: -9.192 vs. CHRS (-40.819). AXON has higher annual earnings (EBITDA): 437M vs. CHRS (37.3M). AXON has more cash in the bank: 986M vs. CHRS (97.7M). CHRS has less debt than AXON: CHRS (270M) vs AXON (722M). AXON has higher revenues than CHRS: AXON (2.08B) vs CHRS (304M).
AXONCHRSAXON / CHRS
Capitalization38.7B94.7M40,866%
EBITDA437M37.3M1,172%
Gain YTD-9.192-40.81923%
P/E Ratio112.443.273,439%
Revenue2.08B304M685%
Total Cash986M97.7M1,009%
Total Debt722M270M267%
FUNDAMENTALS RATINGS
AXON vs CHRS: Fundamental Ratings
AXON
CHRS
OUTLOOK RATING
1..100
8370
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
91
Overvalued
PROFIT vs RISK RATING
1..100
12100
SMR RATING
1..100
47100
PRICE GROWTH RATING
1..100
4087
P/E GROWTH RATING
1..100
6471
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CHRS's Valuation (91) in the Biotechnology industry is in the same range as AXON (92). This means that CHRS’s stock grew similarly to AXON’s over the last 12 months.

AXON's Profit vs Risk Rating (12) in the Biotechnology industry is significantly better than the same rating for CHRS (100). This means that AXON’s stock grew significantly faster than CHRS’s over the last 12 months.

AXON's SMR Rating (47) in the Biotechnology industry is somewhat better than the same rating for CHRS (100). This means that AXON’s stock grew somewhat faster than CHRS’s over the last 12 months.

AXON's Price Growth Rating (40) in the Biotechnology industry is somewhat better than the same rating for CHRS (87). This means that AXON’s stock grew somewhat faster than CHRS’s over the last 12 months.

AXON's P/E Growth Rating (64) in the Biotechnology industry is in the same range as CHRS (71). This means that AXON’s stock grew similarly to CHRS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AXONCHRS
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 15 days ago
73%
Declines
ODDS (%)
Bearish Trend 5 days ago
66%
Bearish Trend 4 days ago
86%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
AXON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CHRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ENLAY8.530.35
+4.28%
ENEL Societa per Azioni
WDOFF11.750.26
+2.26%
Wesdome Gold Mines Ltd.
BKKLY22.73-0.66
-2.82%
Bangkok Bank Public Co Ltd.
EPIAF19.37-0.58
-2.91%
Epiroc Aktiebolag
CNTMF0.05-0.01
-10.00%
FLUENT CORP

AXON and

Correlation & Price change

A.I.dvisor indicates that over the last year, AXON has been loosely correlated with TECH. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if AXON jumps, then TECH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AXON
1D Price
Change %
AXON100%
-3.35%
TECH - AXON
61%
Loosely correlated
-6.03%
VCYT - AXON
58%
Loosely correlated
-5.51%
BEAM - AXON
57%
Loosely correlated
-10.93%
SEER - AXON
56%
Loosely correlated
-1.78%
ADPT - AXON
56%
Loosely correlated
-6.68%
More

CHRS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CHRS has been loosely correlated with ADCT. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if CHRS jumps, then ADCT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CHRS
1D Price
Change %
CHRS100%
-10.28%
ADCT - CHRS
39%
Loosely correlated
-7.52%
ARRY - CHRS
39%
Loosely correlated
-10.32%
AXON - CHRS
38%
Loosely correlated
-3.35%
AMRN - CHRS
35%
Loosely correlated
-2.18%
SRRK - CHRS
34%
Loosely correlated
-5.65%
More